GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

1993 • 23,535 citations

What's wrong with Bonferroni adjustments

1998 • 5,540 citations

Type 1 diabetes: new perspectives on disease pathogenesis and treatment

2001 • 1,477 citations

Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes

2005 • 1,080 citations

β-Cell Function and the Development of Diabetes-Related Complications in the Diabetes Control and Complications Trial

2003 • 657 citations

A Single Course of Anti-CD3 Monoclonal Antibody hOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes

2005 • 622 citations

Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins

1982 • 531 citations

β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

2001 • 513 citations

Randomisation and baseline comparisons in clinical trials

1990 • 492 citations

Declining Incidence of Nephropathy in Insulin-Dependent Diabetes Mellitus

1994 • 455 citations

Beneficial effects of intensive therapy of diabetes during adolescence: Outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT)

2001 • 447 citations

Role of C-peptide in human physiology

2000 • 281 citations

Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes–prone mice

1996 • 266 citations

Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes

2008 • 262 citations

Genetic Effects on Age-Dependent Onset and Islet Cell Autoantibody Markers in Type 1 Diabetes

2002 • 229 citations

Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes

2005 • 220 citations

Insulin Secretion in Type 1 Diabetes

2004 • 162 citations

Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice.

1998 • 149 citations

Plasmapheresis in the initial treatment of insulin-dependent diabetes mellitus in children.

1983 • 142 citations

Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus.

1985 • 126 citations

Diabetes-associated HLA genotypes affect birthweight in the general population

2005 • 110 citations

Heat‐shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: a randomised, double‐blind phase II study

2006 • 108 citations

Low dose linomide in Type I juvenile diabetes of recent onset: a randomised placebo-controlled double blind trial

1998 • 80 citations

Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study)

1995 • 76 citations

A trial of nicotinamide in newly diagnosed patients with Type 1 (insulin-dependent) diabetes mellitus

1990 • 69 citations

Photopheresis at onset of type 1 diabetes: a randomised, double blind, placebo controlled trial

2001 • 65 citations

Insulin as a Primary Autoantigen for Type 1A Diabetes

2005 • 52 citations

Clinical trials of cyclosporin in IDDM.

1988 • 42 citations

Treatment with antioxidants at onset of type 1 diabetes in children: a randomized, double-blind placebo-controlled study

2001 • 37 citations

Immunomodulation with human recombinant autoantigens

2005 • 24 citations

Residual beta-cell function in children with type 1 diabetes: measurement and impact on glycemic control.

1987 • 20 citations

The Prospect of Vaccination to Prevent Type 1 Diabetes

2005 • 18 citations